1.
Clinical lasting response of crizotinib in ALK positive lung squamous cell carcinoma with brain metastasis. Eur J Oncol [Internet]. 2017 Nov. 17 [cited 2024 Apr. 29];22(2):95-7. Available from: https://www.mattioli1885journals.com/index.php/EJOEH/article/view/4800